January 21, 2016

Award is the Highest Honor for Technological Innovation Bestowed by the President of the United States
The White House has awarded Robert E. Fischell, ScD, a member of the University of Maryland School of Medicine (UM SOM) Board of Visitors, the National Medal of Technology and Innovation, the highest honor for technological achievement bestowed by the president of the United States. Previous recipients have included such luminaries as Steven Jobs and Stephen Wozniak (Apple Computer, Inc.), Stephen D. Bechtel, Jr. (Bechtel Group, Inc.), David Packard (Hewlett-Packard Company), Clarence L. Johnson (Lockheed Corporation), Edwin H. Land (Polaroid Corporation) and Edith Flanigen (Union Carbide).
“Robert Fischell’s inventions have been a major benefit to patients and to society as a whole,” said Dean E. Albert Reece, MD, PhD, MBA, who is also Vice President of Medical Affairs at the University of Maryland and the John Z. and Akiko Bowers Distinguished Professor and Dean at UM SOM. “This new honor is richly deserved, and underscores his decades of service.” For years, Fischell and his wife Susan R. Fischell have generously supported UM SOM with major donations and gifts, including the recent endowment of the first Dean’s Professorship in honor of Dean Reece. Claire Fraser, PhD, the Director of the UM SOM Institute for Genomic Sciences, was recently invested as the inaugural Dean’s Endowed Professor of Medicine.
Dr. Fischell is known for inventing life-saving medical devices, and pioneering the modern era of space satellites. He holds more than 200 patents, including nearly 30 patents on orbiting spacecraft. Fischell has invented or helped to invent several important medical devices, including coronary artery stents, the implantable heart defibrillator, the implantable insulin pump, a device to prevent migraine headaches, and a device to prevent death from heart attacks.
Dr. Fischell earned a BS in mechanical engineering at Duke University before relocating to Maryland to work at the U.S. Naval Ordnance Lab, and then the Johns Hopkins Applied Physics Laboratory. In 1953, he earned a master’s degree in physics at the University of Maryland, and in 1996, the university awarded him a doctorate degree.
Dr. Fischell is an active member of the University of Maryland community, serving on the Board of Visitors of the A. James Clark School of Engineering at the University of Maryland, College Park (UMCP). His support helped establish the Fischell Department of Bioengineering in 2006 and Robert E. Fischell Institute for Biomedical Devices at UMCP, which will be inaugurated in 2016.
The National Medal of Technology and Innovation is awarded annually to individuals, teams, companies or divisions of companies for their outstanding contributions to America’s economic, environmental, and social well-being. The purpose of the National Medal of Technology and Innovation is to recognize those who have made lasting contributions to America’s competitiveness, standard of living, and quality of life through technology innovation, and to recognize those who have made substantial contributions to strengthening the nation's technological workforce.
Established by the Stevenson-Wydler Technology Innovation Act of 1980, the medal was first awarded in 1985, and is administered for the White House by the U.S. Department of Commerce’s Patent and Trademark Office. Fischell and other recipients of the National Medal of Technology and Innovation will receive their medals at a White House ceremony.
Fischell is a member of the National Academy of Engineering, and is the recipient of many major honors, including the Inventor of the Year for the United States in 1983, induction into the Space Technology Hall of Fame and the Clark School’s Innovation Hall of Fame and an honorary Doctorate for Humane letters from the Johns Hopkins University in 2008.
About the University of Maryland School of Medicine
The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes, and a faculty of more than 3,000 physicians and research scientists and more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world.
medschool.umaryland.edu
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories
.jpg)
Wednesday, March 01, 2023
Internationally-Renowned Scientist Claire Fraser, PhD, To Step Down as Director of the University of Maryland School of Medicine's Institute for Genome Sciences
Claire Fraser, PhD, a pioneer and global leader in genomic research, has announced that she will step down from her position as Director of the Institute for Genome Sciences (IGS) in the University of Maryland School of Medicine (UMSOM). She will now continue as the Dean E. Albert Reece Endowed Professor and Professor of Medicine and Microbiology and Immunology at UMSOM and scientist at IGS until she retires in 2024.

Thursday, June 23, 2022
New Research Shows Mothers’ HIV Status, Breastfeeding, and the Infant Gut Microbiome Can Have Long-Term Impact on Infant Health
Babies born to women with HIV often have poorer health and under-developed growth in the early months of life than infants born to women without the infection — even if those babies don’t contract HIV during birth, according to a new study by researchers at the University of Maryland School of Medicine (UMSOM)’s Institute for Genome Sciences (IGS) and Institute of Human Virology (IHV). The study also provides new insights into why these health issues often continue throughout the babies’ lives.
.jpg)
Wednesday, September 15, 2021
Probiotic-Containing Yogurt Protects Against Microbiome Changes That Lead to Antibiotic-Induced Diarrhea, Study Finds
Eating yogurt containing a particular strain of a well-studied probiotic appears to protect against harmful changes in the gut microbiome that are associated with antibiotic administration. That is the finding from a new randomized clinical trial, led by researchers at the University of Maryland School of Maryland (UMSOM), the University of Maryland School of Pharmacy (UMSOP), and Georgetown University Medical Center, which was recently published in the journal Nutrients.

Thursday, March 18, 2021
UM School of Medicine Helps Maryland Conduct State-Wide Sequencing of Variants in Positive COVID-19 Test Specimens
In an effort to monitor the spread of COVID-19 variants in the State of Maryland, University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced that UMaryland Genomics at UMSOM will perform genome sequencing of variants in at least 10 percent of COVID-19 test samples, reaching an important benchmark set by the federal government to help control the spread of these variants.

Tuesday, February 12, 2019
UMSOM Scientists Call for Unrestricted Usage of Public Genome Data
Researchers at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM) called for open access to genome data, stating that unrestricted usage is needed for progress in combating the world’s most serious diseases.

Tuesday, December 04, 2018
UMSOM/UMSOP Researchers Awarded $1.78 Million Grant to Study Brain-To-Gut Connection in Schizophrenia
Researchers at the University of Maryland School of Medicine’s (UMSOM) Maryland Psychiatric Center (MPRC) and Institute for Genome Sciences (IGS), along with researchers at the University of Maryland School of Pharmacy (UMSOP), have been awarded a collaborative five-year $1.78 million grant to study the brain-to-gut connection in schizophrenia.

Friday, May 11, 2018
2018 University of Maryland School of Medicine Gala Celebrates Impassioned Care, Inspired Discoveries
The air was filled with history, enthusiasm, and appreciation on a warm spring evening as more than 1,000 business and community leaders, donors, faculty, staff, students, and other distinguished guests gathered for the University of Maryland School of Medicine’s Annual Gala in Baltimore. The School of Medicine Gala coincides annually with the Medical Alumni Association Reunion Weekend.

Monday, May 07, 2018
UM School of Medicine to Become Major Center for Bioengineering Innovation with Transformational Gift from Entrepreneurial Leader and Longtime Benefactor Robert E. Fischell
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the UMSOM will receive $20 million in philanthropic support from one of its most distinguished, long-time board members and benefactors, Robert E. Fischell, ScD.

Thursday, April 21, 2016
Dean E Albert Reece and SOM Board Member Robert Fischell Inducted into National Academy of Inventors
Dean E. Albert Reece, MD, PhD, MBA, Vice President of Medical Affairs at the University of Maryland and the John Z. and Akiko Bowers Distinguished Professor and Dean at UM SOM and Robert E. Fischell, ScD, a member of the University of Maryland School of Medicine (UM SOM) Board of Visitors, were recently honored at the induction ceremony of the 2015 Fellows of the National Academy of Inventors at the NAI's fifth annual conference, held this year in Washington D.C. on Apr. 14-15.
Monday, February 08, 2016
UM SOM Researchers Identify Most Dangerous Strains of Often-Deadly Bacteria
A multi-disciplinary group of researchers at the University of Maryland School of Medicine (UM SOM) have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.